So, the core concept would be about how different inhalation anesthetics affect systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR), which is crucial in managing a PDA. Since PDA is a left-to-right shunt, increasing SVR can increase the shunt, while decreasing SVR reduces it. Therefore, the goal is to use an agent that doesn't significantly alter SVR or PVR.
The correct answer is likely sevoflurane. Why? Because sevoflurane has minimal effects on SVR and PVR. It's known for being a smooth inducer with less irritation, making it suitable for children. Also, it doesn't cause significant cardiovascular depression, which is important in a child with heart failure.
Now, looking at the options. Let's assume the options were sevoflurane, isoflurane, desflurane, and halothane. Wait, the original question didn't list the options, but the correct answer is probably sevoflurane. Let me check the reasoning again. Sevoflurane is preferred in pediatric cases for induction because it's less irritating and has a more favorable hemodynamic profile. Desflurane can cause bronchospasm and is more irritating, so less likely. Isoflurane and halothane might have more pronounced effects on SVR/PVR.
Wait, halothane is known to increase PVR, which is bad in PDA. Desflurane can cause tachycardia and may increase SVR. Isoflurane causes a decrease in SVR but might have more cardiovascular depression. So sevoflurane is the best choice here.
The clinical pearl here is to remember that in patients with PDA, maintaining SVR is important to minimize the shunt. Therefore, using an anesthetic that doesn't alter SVR much is key. Sevoflurane is the go-to for this scenario.
**Core Concept**
Patent ductus arteriosus (PDA) creates a left-to-right shunt, where systemic vascular resistance (SVR) inversely affects pulmonary blood flow. Inhalation anesthetics that minimally alter SVR/PVR are preferred to avoid worsening shunting or hemodynamic instability.
**Why the Correct Answer is Right**
**Sevoflurane** is the optimal choice because it has minimal effects on SVR and PVR, preserving hemodynamic stability. It causes mild myocardial depression but maintains coronary perfusion, making it safe in cardiac failure. Its smooth induction profile and low airway irritation are ideal for pediatric patients, reducing stress and tachycardia that could exacerbate PDA shunting.
**Why Each Wrong Option is Incorrect**
**Option A: Halothane** increases pulmonary vascular resistance (PVR), worsening right-to-left shunting in PDA.
**Option B: Desflurane** is highly irritating, causing coughing and increased intrathoracic pressure, which may elevate PVR
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.